{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:24:36Z","timestamp":1793993076436,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA046048"],"award-info":[{"award-number":["R21DA046048"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["R01CE003009"],"award-info":[{"award-number":["R01CE003009"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI007001"],"award-info":[{"award-number":["T32AI007001"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32AI070114"],"award-info":[{"award-number":["T32AI070114"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005539","name":"Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill","doi-asserted-by":"publisher","award":["UL1TR001111"],"award-info":[{"award-number":["UL1TR001111"]}],"id":[{"id":"10.13039\/100005539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.drugalcdep.2022.109727","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:52:08Z","timestamp":1670547128000},"page":"109727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Intended and unintended consequences: Changes in opioid prescribing practices for postsurgical, acute, and chronic pain indications following two policies in North Carolina, 2012\u20132018 \u2013 Controlled and single-series interrupted time series analyses"],"prefix":"10.1016","volume":"242","author":[{"given":"Courtney N.","family":"Maierhofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbar I.","family":"Ranapurwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany L.","family":"DiPrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Fulcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Ringwalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Chelminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Ives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabarun","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian F.","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"Pence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.drugalcdep.2022.109727_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18361","article-title":"Association of state opioid duration limits with postoperative opioid prescribing","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2022.109727_bib2","unstructured":"Agency for Healthcare Research and Quality, 2019. Healthcare Cost and Utilization Project (HCUP). HCUP Tools and Software. Accessed July 2021. Retrieved from \u3008https:\/\/www.hcup-us.ahrq.gov\/tools_software.jsp\u3009."},{"issue":"7748","key":"10.1016\/j.drugalcdep.2022.109727_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","article-title":"Scientists rise up against statistical significance","volume":"567","author":"Amrhein","year":"2019","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.drugalcdep.2022.109727_bib4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jama.2017.0935","article-title":"History of the joint commission\u2019s pain standards: lessons for today\u2019s prescription opioid epidemic","volume":"317","author":"Baker","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109727_bib5","first-page":"348","article-title":"Interrupted time series regression for the evaluation of public health interventions: a tutorial","volume":"46","author":"Bernal","year":"2017","journal-title":"Int. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109727_bib6","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1093\/ije\/dyy135","article-title":"The use of controls in interrupted time series studies of public health interventions","volume":"47","author":"Bernal","year":"2018","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2022.109727_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108248","article-title":"The association between opioid discontinuation and heroin use: a nested case-control study","volume":"217","author":"Binswanger","year":"2020","journal-title":"Drug Alcohol. Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109727_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1056\/NEJMra1802148","article-title":"Understanding links among opioid use, overdose, and suicide","volume":"380","author":"Bohnert","year":"2019","journal-title":"NEJM"},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109727_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the centers for disease control and prevention\u2019s 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.drugalcdep.2022.109727_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1526-4637.2006.00187.x","article-title":"DEA, administrative action statistics, and pain management: it is time to get real","volume":"7","author":"Bolen","year":"2006","journal-title":"Pain. Med"},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109727_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg."},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109727_bib12","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s11606-018-4335-8","article-title":"Prediction of future chronic opioid use among hospitalized patients","volume":"33","author":"Calcaterra","year":"2018","journal-title":"J. Gen. Intern. Med"},{"key":"10.1016\/j.drugalcdep.2022.109727_bib13","unstructured":"Centers for Disease Control and Prevention, 2013. Prescription Drug Overdose Data & Statistics: Guide to ICD-9-CM and ICD-10 Codes Related to Poisoning and Pain. Accessed July 2021. Retrieved from \u3008http:\/\/www.cdc.gov\/nchs\/icd.htm\u3009."},{"key":"10.1016\/j.drugalcdep.2022.109727_bib14","unstructured":"Centers for Disease Control and Prevention, 2019. CDC Advises Against Misapplication of the Guideline for Prescribing Opioids for Chronic Pain. Accessed July 2021. Retrieved from \u3008https:\/\/www.cdc.gov\/media\/releases\/2019\/s0424-advises-misapplication-guideline-prescribing-opioids.html\u3009."},{"key":"10.1016\/j.drugalcdep.2022.109727_bib15","unstructured":"Centers for Disease Control and Prevention, 2020. US Opioid Dispensing Rate Maps. Accessed July 2021. Retrieved from \u3008https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/index.html\u3009."},{"key":"10.1016\/j.drugalcdep.2022.109727_bib16","unstructured":"Centers for Disease Control and Prevention, 2021. National Center for Injury Prevention and Control. Opioid Overdose: Data Resources. Analyzing prescription data and morphine milligram equivalents (MME). Accessed July 2021. Retrieved from \u3008https:\/\/www.cdc.gov\/opioids\/data-resources\/index.html\u3009."},{"issue":"5","key":"10.1016\/j.drugalcdep.2022.109727_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232538","article-title":"Illicit opioid use following changes in opioids prescribed for chronic non-cancer pain","volume":"15","author":"Coffin","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109727_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm. Rep."},{"issue":"24","key":"10.1016\/j.drugalcdep.2022.109727_bib19","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMp1904190","article-title":"No shortcuts to safer opioid prescribing","volume":"380","author":"Dowell","year":"2019","journal-title":"NEJM"},{"key":"10.1016\/j.drugalcdep.2022.109727_bib20","unstructured":"U.S. Food and Drug Administration, 2017. FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. FDA. Accessed July 2022. Retrieved from \u3008https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or\u3009."},{"key":"10.1016\/j.drugalcdep.2022.109727_bib21","unstructured":"General Assembly of North Carolina Session, 2017. Session Law 2017\u201374: House Bill 243. Accessed July 2021. Retrieved from \u3008https:\/\/www.ncmedboard.org\/images\/uploads\/article_images\/H243v7.pdf\u3009."},{"issue":"7","key":"10.1016\/j.drugalcdep.2022.109727_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.16860","article-title":"Changes in initial opioid prescribing practices after the 2016 release of the CDC guideline for prescribing opioids for chronic pain","volume":"4","author":"Goldstick","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109727_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.japh.2018.09.005","article-title":"Associations between initial opioid exposure and the likelihood for long-term use","volume":"59","author":"Hadlandsmyth","year":"2019","journal-title":"J. Am. Pharm. Assoc."},{"issue":"5","key":"10.1016\/j.drugalcdep.2022.109727_bib24","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1213\/ANE.0000000000002458","article-title":"Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic","volume":"125","author":"Hah","year":"2017","journal-title":"Anesth. Analg."},{"issue":"11","key":"10.1016\/j.drugalcdep.2022.109727_bib25","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1007\/s11606-020-06192-4","article-title":"Prescription opioid dispensing patterns prior to heroin overdose in a state medicaid program: a case-control study","volume":"35","author":"Hartung","year":"2020","journal-title":"J. Gen. Intern. Med"},{"issue":"8","key":"10.1016\/j.drugalcdep.2022.109727_bib26","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/pm\/pnab017","article-title":"Changes in quantity of opioids dispensed following Florida\u2019s restriction law for acute pain prescriptions","volume":"22","author":"Hincapie-Castillo","year":"2021","journal-title":"Pain. Med"},{"key":"10.1016\/j.drugalcdep.2022.109727_bib27","unstructured":"International Committee of Medical Journal Editors (ICMJE), 2013. The New ICMJE Recommendations (August 2013). Accessed July 2022. Retrieved from \u3008http:\/\/www.icmje.org\/news-and-editorials\/new_rec_aug2013.html\u3009."},{"issue":"4","key":"10.1016\/j.drugalcdep.2022.109727_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1526-4637.2006.00164.x","article-title":"The risk of action by the drug enforcement administration against physicians prescribing opioids for pain","volume":"7","author":"Jung","year":"2006","journal-title":"Pain. Med"},{"issue":"4","key":"10.1016\/j.drugalcdep.2022.109727_bib29","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/pm\/pny307","article-title":"Challenges with implementing the centers for disease control and prevention opioid guideline: A CONSENSUS PANEL REport","volume":"20","author":"Kroenke","year":"2019","journal-title":"Pain. Med"},{"issue":"2","key":"10.1016\/j.drugalcdep.2022.109727_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36687","article-title":"Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.drugalcdep.2022.109727_bib31","first-page":"648","article-title":"Potential misuse and inappropriate prescription practices involving opioid analgesics","volume":"19","author":"Liu","year":"2013","journal-title":"Am. J. Manag. Care"},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109727_bib32","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMp1803661","article-title":"Opioid prescribing limits for acute pain \u2014 striking the right balance","volume":"379","author":"Lowenstein","year":"2018","journal-title":"NEJM"},{"key":"10.1016\/j.drugalcdep.2022.109727_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/pm\/pnab181","article-title":"Association between statewide opioid prescribing interventions and opioid prescribing patterns in North Carolina, 2006\u20132018","author":"Maierhofer","year":"2021","journal-title":"Pain. Med"},{"issue":"5","key":"10.1016\/j.drugalcdep.2022.109727_bib34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4514","article-title":"Indication-specific opioid prescribing for US patients with medicaid or private insurance, 2017","volume":"3","author":"Mikosz","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"5","key":"10.1016\/j.drugalcdep.2022.109727_bib35","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/pds.4322","article-title":"Patterns of opioid initiation at first visits for pain in United States primary care settings","volume":"27","author":"Mundkur","year":"2018","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"10.1016\/j.drugalcdep.2022.109727_bib36","first-page":"84","article-title":"Characterizing patients after opioid taper in a VA medical center","volume":"35","author":"Muzzio","year":"2021","journal-title":"J. Pain. Palliat. Care Pharm."},{"key":"10.1016\/j.drugalcdep.2022.109727_bib37","doi-asserted-by":"crossref","unstructured":"National Academies of Sciences, Engineering, and Medicine, 2017. Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use. Washington, DC: The National Academies Press. Accessed July 2021. Retrieved from \u3008https:\/\/doi.org\/10.17226\/24781\u3009.","DOI":"10.17226\/24781"},{"key":"10.1016\/j.drugalcdep.2022.109727_bib38","unstructured":"North Carolina Medical Board, 2016. North Carolina Medical Board Annual Report. Accessed July 2021. Retrieved from \u3008https:\/\/www.ncmedboard.org\/images\/uploads\/disciplinary_reports\/2016_Annual_Report1.pdf\u3009."},{"key":"10.1016\/j.drugalcdep.2022.109727_bib39","unstructured":"North Carolina Medical Board, 2017. Bill Summary: The Strengthen Opioid Misuse Prevention (STOP) Act of 2017. Accessed July 2021. Retrieved from \u3008https:\/\/www.ncmedboard.org\/images\/uploads\/article_images\/The_STOP_Act_summary-OnLetterhead.pdf\u3009."},{"key":"10.1016\/j.drugalcdep.2022.109727_bib40","unstructured":"North Carolina Medical Society, 2017. NC Medical Board Refines Safe Opioid Prescribing Initiative Criteria. Accessed July 2021. Retrieved from \u3008https:\/\/www.ncmedsoc.org\/nc-medical-board-refines-safe-opioid-prescribing-initiative-criteria\/\u3009."},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109727_bib41","first-page":"779","article-title":"Changes in Schedule II oral opioid volume dispensed in a private health plan following Florida\u2019s acute pain opioid restriction law","volume":"27","author":"Oueini","year":"2021","journal-title":"J. Manag. Care Spec. Pharm."},{"issue":"8","key":"10.1016\/j.drugalcdep.2022.109727_bib42","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/j.pain.0000000000001242","article-title":"Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study","volume":"159","author":"Pasricha","year":"2018","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.drugalcdep.2022.109727_bib43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1526-4637.2006.00189.x","article-title":"Fear and loathing in the pain clinic","volume":"7","author":"Passik","year":"2006","journal-title":"Pain. Med"},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109727_bib44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11606-019-05227-9","article-title":"Opioid taper is associated with subsequent termination of care: a retrospective cohort study","volume":"35","author":"Perez","year":"2020","journal-title":"J. Gen. Intern. Med"},{"key":"10.1016\/j.drugalcdep.2022.109727_bib45","article-title":"State medical board policy and opioid prescribing: a controlled interrupted time series","author":"Ranapurwala","year":"2020","journal-title":"Am. J. Prev. Med."},{"issue":"11","key":"10.1016\/j.drugalcdep.2022.109727_bib46","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jpain.2017.06.010","article-title":"Factors influencing long-term opioid use among opioid naive patients: an examination of initial prescription characteristics and pain etiologies","volume":"18","author":"Shah","year":"2017","journal-title":"J. Pain."},{"issue":"2","key":"10.1016\/j.drugalcdep.2022.109727_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am. Stat."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871622004641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871622004641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:25:42Z","timestamp":1759829142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871622004641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":47,"alternative-id":["S0376871622004641"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109727","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intended and unintended consequences: Changes in opioid prescribing practices for postsurgical, acute, and chronic pain indications following two policies in North Carolina, 2012\u20132018 \u2013 Controlled and single-series interrupted time series analyses","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109727"}}